Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Erythema, Fatigue
Clinical narrative: Tenderness and pain in the injection site; injection site was swollen; had tender lymph node under the right arm under the injection site; had tender lymph node under the right arm under the injection site and rash; Slept and slept for hours; was sore all over; Loss of appetite; Redness; patient had muscle and joint pain; Joint pain; had fatigue; Chills; Headache; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (Slept and slept for hours), PAIN (was sore all over), DECREASED APPETITE (Loss of appetite), ERYTHEMA (Redness) and MYALGIA (patient had muscle and joint pain) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038A22A, 030M20A, 002A21A and 939903) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Flu (before the 1st dose of moderna vaccine). Concomitant products included ATENOLOL for an unknown indication.   On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jun-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jun-2022, the patient experienced SOMNOLENCE (Slept and slept for hours), PAIN (was sore all over), DECREASED APPETITE (Loss of appetite), ERYTHEMA (Redness), MYALGIA (patient had muscle and joint pain), ARTHRALGIA (Joint pain), FATIGUE (had fatigue), CHILLS (Chills) and HEADACHE (Headache). On an unknown date, the patient experienced VACCINATION SITE PAIN (Tenderness and pain in the injection site), VACCINATION SITE SWELLING (injection site was swollen), VACCINATION SITE LYMPHADENOPATHY (had tender lymph node under the right arm under the injection site) and VACCINATION SITE RASH (had tender lymph node under the right arm under the injection site and rash). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (Slept and slept for hours), PAIN (was sore all over), DECREASED APPETITE (Loss of appetite), ERYTHEMA (Redness), MYALGIA (patient had muscle and joint pain), ARTHRALGIA (Joint pain), FATIGUE (had fatigue), CHILLS (Chills), HEADACHE (Headache), VACCINATION SITE PAIN (Tenderness and pain in the injection site), VACCINATION SITE SWELLING (injection site was swollen), VACCINATION SITE LYMPHADENOPATHY (had tender lymph node under the right arm under the injection site) and VACCINATION SITE RASH (had tender lymph node under the right arm under the injection site and rash) outcome was unknown.            The patient had no allergic history. The patient stated that she had a list of side effects that she was experiencing from the second booster dose of Moderna vaccine.   This case was linked to MOD-2022-594662 (Patient Link).